Company Filing History:
Years Active: 2016-2019
Title: Innovations of Supriya Munshaw in Hepatitis C Research
Introduction
Supriya Munshaw, an accomplished inventor based in Baltimore, MD, has made significant contributions to the field of hepatitis C research. With two notable patents to her name, her innovative work focuses on the synthetic representation of hepatitis C subtypes and the methods for creating and utilizing them.
Latest Patents
Supriya Munshaw's latest patents include innovative technologies that produce synthetic hepatitis C polypeptides. Her first patent details methods for making and using synthetic representative HCV subtypes, namely Bole1a and Bole1b, through a novel approach employing Bayesian phylogenetic tree analysis, ancestral sequence reconstruction, and covariance analysis. Bole1a is notable for its central branching among a dataset of 390 full-genome sequences, demonstrating remarkable coverage of 94% and 78% respectively for non-synonymous diversity and 9-mer peptide coverage when compared to traditional reference sequences. Furthermore, Bole1a offers unparalleled epitope coverage compared to known T cell epitopes, positioning it as a vital tool in hepatitis C research.
Her second patent closely mirrors the first, reinforcing the significance of Bole1a and Bole1b in synthetic hepatitis C genome development, further affirming their representational accuracy of widely circulating strains.
Career Highlights
Supriya Munshaw is associated with The Johns Hopkins University, where her research focuses on tackling the challenges posed by hepatitis C. Her work has garnered attention in the scientific community, showcasing the impactful innovations that can arise from a solid research foundation and cutting-edge methodologies.
Collaborations
Throughout her career, Munshaw has collaborated with prominent colleagues in her field, including noted researchers Stuart Campbell Ray and Lin Liu. These collaborations underscore the importance of teamwork in advancing medical research and developing innovative solutions.
Conclusion
Supriya Munshaw's contributions to hepatitis C research exemplify the power of innovation in medicine. Her patents not only reflect a deep understanding of viral genetics but also highlight her commitment to addressing significant health challenges. As she continues her research at The Johns Hopkins University, the scientific community eagerly anticipates her future discoveries and advancements in the field.